SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-20-021136
Filing Date
2020-02-14
Accepted
2020-02-14 11:39:35
Documents
1
Group Members
VERSANT AFFILIATES FUND V, L.P.VERSANT OPHTHALMIC AFFILIATES FUND I, L.P.VERSANT VENTURE CAPITAL V (CANADA) LPVERSANT VENTURES V (CANADA), L.P.VERSANT VENTURES V GP-GP (CANADA), INC.VERSANT VENTURES V, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A a20-8045_1sc13ga.htm SC 13G/A 247476
  Complete submission text file 0001104659-20-021136.txt   249313
Mailing Address ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104
Business Address ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104 650-233-7877
Versant Venture Capital V, L.P. (Filed by) CIK: 0001589097 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Subject) CIK: 0001658247 (see all company filings)

IRS No.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90577 | Film No.: 20616049
SIC: 2834 Pharmaceutical Preparations